Health Care Reform

Companies think the 2027 price increases will be in line with the underlying medical cost increases.

Urban Institute researchers say coverage losses, Medicaid funding constraints and workforce pressures could compound hospitals' financial challenges.

The rise of direct-to-consumer testing could affect employer plans' ability to track enrollee risk.

The SUSTAIN Act would end the pilot program less than a year after it begins, codify upfront point-of-sale discounts and terminate drug manufacturer-imposed limits on when, where and how safety-net hospitals and clinics can access legally mandated drug discounts.

The court left open the possibility that insurance restrictions may create a distinct cash-pay market for weight-loss drugs.

The rules are part of a major independent dispute resolution system reboot.